OTC Markets OTCPK - Delayed Quote USD

Embla Medical hf. (OSSFF)

Compare
4.8067 0.0000 (0.00%)
At close: October 25 at 4:00 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
840,305.0000
785,683.0000
718,650.0000
718,669.0000
629,503.0000
Cost of Revenue
319,173.0000
300,110.0000
278,902.0000
263,282.0000
238,268.0000
Gross Profit
521,132.0000
485,573.0000
439,748.0000
455,387.0000
391,235.0000
Operating Expense
416,002.0000
398,113.0000
372,609.0000
359,763.0000
337,969.0000
Operating Income
105,130.0000
87,460.0000
67,139.0000
95,624.0000
53,266.0000
Net Non Operating Interest Income Expense
-20,681.0000
-16,112.0000
-11,641.0000
-12,186.0000
-9,978.0000
Pretax Income
89,849.0000
76,007.0000
56,172.0000
86,640.0000
12,720.0000
Tax Provision
20,494.0000
17,206.0000
12,962.0000
20,984.0000
4,799.0000
Net Income Common Stockholders
69,066.0000
58,389.0000
42,513.0000
63,994.0000
6,214.0000
Diluted NI Available to Com Stockholders
69,066.0000
58,389.0000
42,513.0000
63,994.0000
6,214.0000
Basic EPS
0.16
0.14
0.10
0.16
0.01
Diluted EPS
0.16
0.14
0.10
0.15
0.01
Basic Average Shares
427,538.0790
420,297.0000
417,758.0000
422,161.0000
421,775.0000
Diluted Average Shares
427,559.0790
420,318.0000
417,831.0000
422,795.0000
422,725.0000
Total Operating Income as Reported
105,917.0000
89,387.0000
64,844.0000
97,311.0000
28,288.0000
Total Expenses
735,175.0000
698,223.0000
651,511.0000
623,045.0000
576,237.0000
Net Income from Continuing & Discontinued Operation
69,066.0000
58,389.0000
42,513.0000
63,994.0000
6,214.0000
Normalized Income
69,066.0000
58,389.0000
42,513.0000
63,994.0000
6,214.0000
Interest Income
2,181.0000
3,448.0000
779.0000
168.0000
459.0000
Interest Expense
21,261.0000
17,959.0000
11,204.0000
9,798.0000
9,611.0000
Net Interest Income
-20,681.0000
-16,112.0000
-11,641.0000
-12,186.0000
-9,978.0000
EBIT
111,110.0000
93,966.0000
67,376.0000
96,438.0000
22,331.0000
EBITDA
165,302.0000
143,886.0000
116,741.0000
147,966.0000
87,030.0000
Reconciled Cost of Revenue
319,173.0000
300,110.0000
278,902.0000
263,282.0000
238,268.0000
Reconciled Depreciation
54,192.0000
49,920.0000
49,365.0000
51,528.0000
64,699.0000
Net Income from Continuing Operation Net Minority Interest
69,066.0000
58,389.0000
42,513.0000
63,994.0000
6,214.0000
Normalized EBITDA
165,302.0000
143,886.0000
116,741.0000
147,966.0000
87,030.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0004
12/31/2020 - 5/23/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers